tiprankstipranks
Genetic Technologies Ltd (GENE)
NASDAQ:GENE

Genetic Technologies (GENE) Stock Investors

467 Followers
Based on 730,641 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

- of all portfolios hold GENE
On average, investors allocate 0.00% of their portfolios to GENE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently there is not enough data
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GENE

-
Last 7
Days
-
Last 30
Days
Percentages indicate the change in the number of portfolios holding GENE, out of 730,641 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GENE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$2.69
Based on the activity of 13,718 investors who made their portfolios public
The table shows changes in GENE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GENE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Marathon Digital Holdings
5.61%
-0.28%
-0.34%
5.49B
Financial
GE Aerospace
5.52%
+1.76%
+11.46%
177.79B
Industrials
Riot Platforms
5.21%
+2.89%
+4.66%
3.00B
Financial
Blink Charging Co
5.06%
-1.40%
-5.24%
237.33M
Industrials
ChargePoint Holdings
3.88%
-0.93%
-4.35%
567.30M
Consumer Cyclical
AMC Entertainment
5.48%
-1.15%
-4.00%
893.62M
Communication Services
Plug Power
4.89%
-1.23%
-4.33%
1.77B
Industrials
Merck & Company
4.12%
+0.29%
+1.57%
321.34B
Healthcare
Block
4.49%
-0.83%
-5.04%
46.31B
Technology
Boeing
5.82%
-0.29%
+0.18%
103.22B
Industrials
Based on the activity of 730,641 active portfolios
Open your Smart Portfolio

GENE Investor Analysis

GENE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.6%
of GENE holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
GENE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.6%
of GENE holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
GENE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.8%
of GENE holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of GENE stock investors
See who invests in GENE according to age group and performance.

FAQ

How many retail Investors hold GENE?
Currently, no data Available
What is GENE Investor Sentiment?
Currently, no data Available
What percentage of retail investors changed their holding of GENE in the last 7 days?
Currently, no data Available
What percentage of retail investors changed their holding of GENE in the last 30 days?
Currently, no data Available
What is the average age of retail investors who hold GENE?
The average age of GENE Holders is over 55.
    What other stocks have GENE investors also bought?
    GENE Investors also bought MARA, GE, RIOT, BLNK, CHPT, AMC, PLUG, MRK, SQ, BA.
      Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
      AGENAgenus
      BAXBaxter International
      BMRNBioMarin Pharmaceutical
      CORTCorcept Therapeutics
      GERNGeron
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis